GlassScriptPhysician profile
Arlene Shaw
NPI 1982227575
$2,691.11
in general payments reported to CMS, 2019-2025
26 companies · $327 in 2025
The $327 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $380 · 2022: $661 · 2023: $804 · 2024: $519 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,615 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,614.53 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $425.52 | 2021-2023 | Erleada |
| Urovant Sciences INC | $312.26 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $243.82 | 2023-2025 | Gemtesa |
| Myriad Genetic Laboratories, INC. | $163.56 | 2021-2024 | Prolaris |
| Pfizer INC. | $147.67 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $139.67 | 2023-2025 | |
| Myovant Sciences INC. | $135.97 | 2022 | |
| Boston Scientific Corporation | $133.42 | 2024 | Rezum Generator |
| Allergan, INC. | $124.99 | 2022 | |
| Astellas Pharma US INC | $105.84 | 2021-2025 | Xtandi, Padcev |
| Antares Pharma, INC. | $97.75 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Teleflex LLC | $91.58 | 2024-2025 | Urolift |
| Clarus Therapeutics INC. | $83.61 | 2021 | |
| Medtronic, INC. | $76.98 | 2025 | Interstim |
| Tolmar Pharmaceuticals, INC. | $73.94 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $56.29 | 2023-2025 | Imfinzi |
| Urogen Pharma, INC. | $54.43 | 2023-2025 | Jelmyto |
| Laborie Medical Technologies Corp. | $42.45 | 2024-2025 | Urgent PC Neuromodulation System |
| Tolmar, INC. | $34.30 | 2023 | |
| Abbvie INC. | $28.38 | 2021-2022 | |
| Telix Pharmaceuticals | $25.77 | 2024 | Illuccix |
| 180 Medical, INC. | $23.83 | 2024 | |
| Blue Earth Diagnostics | $22.07 | 2024 | |
| Amgen INC. | $19.17 | 2021 | |
| Endo Pharmaceuticals INC. | $15.62 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arlene Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.